Glucocorticoid resistance-induced inflammation drives cardiovascular–kidney–metabolic (CKM) syndrome pathophysiology
Trends in Endocrinology & Metabolism · 2026-06
DOI: 10.1016/j.tem.2026.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-06. Verfasst von Genesee J Martinez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexingt…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Prolonged activation of the hypothalamic-pituitary-adrenal axis results in excessive secretion of the glucocorticoid (GC) hormone cortisol, which contributes to weight gain, increased appetite, and inflammation. GCs are essential in regulating stress responses and suppressing immune functions. They bind to the GC receptor and influence gene expression through transcriptional mechanisms. Sustained elevation of GC levels may lead to GC resistance, thereby contributing to inflammation, adiposity, and insulin resistance, which negatively impact the hepatic, cardiovascular, and renal systems. This condition is referred to as cardiovascular-kidney-metabolic (CKM) syndrome. The notable pathologies associated with GC resistance and CKM syndrome are discussed, with particular emphasis on CKM staging and potential therapeutic strategies for individuals with cardiometabolic dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, USA.
- Department of Physiology and Biophysics, Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson, MS, USA.
- Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, USA; Barnstable Brown Diabetes Center, University of Kentucky…
Förderung
- NIDA NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- American Heart Association Inc
- National Institute of General Medical Sciences
- Foundation for the National Institutes of Health
- National Heart Lung and Blood Institute
Zitieren
APA
Martinez, G. J., Stec, D. E., & Hinds, T. D. (2026). Glucocorticoid resistance-induced inflammation drives cardiovascular–kidney–metabolic (CKM) syndrome pathophysiology. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2026.05.004
Vancouver
Martinez GJ, Stec DE, Hinds TD. Glucocorticoid resistance-induced inflammation drives cardiovascular–kidney–metabolic (CKM) syndrome pathophysiology. Trends in Endocrinology & Metabolism. 2026. doi:10.1016/j.tem.2026.05.004
BibTeX
@article{Martinez2026,
author = {Martinez, Genesee J and Stec, David E and Hinds, Terry D},
title = {Glucocorticoid resistance-induced inflammation drives cardiovascular–kidney–metabolic (CKM) syndrome pathophysiology},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
doi = {10.1016/j.tem.2026.05.004}
}
EUVIMED